文献速递神经肿瘤神经重症

免疫肿瘤治疗(IO)诱发脑炎模拟脑转移的病例报告:一例有创伤性脑损伤史的患者

Case Report of Immuno-Oncotherapy (IO) Provoked Encephalitis Mimicking Brain Metastasis in a Patient with History of Traumatic Brain Injury.
PubMed 文献 · World Neurosurg · 2020-04-30

本文报告一例70岁透明细胞肾细胞癌伴肺转移男性患者,在改用单药纳武利尤单抗免疫肿瘤治疗后出现新发全面性强直-阵挛发作和左侧视野缺损。脑影像见右侧枕部实性强化肿块,疑似转移瘤或淋巴瘤。脑脊液细胞学恶性阴性但提示淋巴增殖性过程。停用免疫肿瘤治疗并给予类固醇后患者临床改善,结论为免疫肿瘤治疗继发免疫介导性脑炎,反应性T细胞聚集于既往创伤性脑损伤所致脑软化区形成肿块样表现。

要点

  • 免疫肿瘤治疗(IO)患者新发癫痫可能提示脑炎。
  • 有创伤性脑损伤(TBI)和脑软化史者需考虑中枢神经系统转移模拟。
  • 脑软化区可局限反应性淋巴细胞,形成肿块样外观。

核心结论

  • 诊断为免疫肿瘤治疗继发免疫介导性脑炎,反应性T细胞聚集于既往创伤性脑损伤所致脑软化区。
  • 既往创伤性脑损伤所致脑软化区局限了反应性淋巴细胞,形成肿块样外观。
  • 免疫肿瘤治疗患者新发癫痫可能提示脑炎,有创伤性脑损伤和脑软化史者应考虑中枢神经系统转移模拟。

研究设计与样本

  • 病例报告,报告一例70岁透明细胞肾细胞癌伴肺转移男性患者。

主要发现

  • 患者在接受肺照射、肾切除术和化疗后改用单药纳武利尤单抗免疫肿瘤治疗,出现新发全面性强直-阵挛发作和左侧视野缺损。
  • 脑影像见右侧枕部实性强化肿块,推测为转移瘤或淋巴瘤。
  • 脑脊液细胞学恶性阴性,但提示淋巴增殖性过程,未确定为恶性。
  • 患者开始类固醇和抗癫痫治疗,全身肿瘤再分期阴性后停用免疫肿瘤治疗并给予类固醇,患者临床改善。

临床怎么用

  • 作者认为,免疫肿瘤治疗患者新发癫痫可能提示脑炎。
  • 作者认为,有创伤性脑损伤和脑软化史的患者应考虑中枢神经系统转移模拟。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Immuno-oncotherapy (IO) has revolutionized systemic cancer care but remains experimental in brain tumors. IO treatment risks multiorgan autoimmune inflammatory responses that limit its use. The central nervous system (CNS) is an immune-specialized compartment with restricted cellular access, thus fewer cases are reported for immune-mediated encephalitis. Interestingly, patients with history of blood-brain barrier compromise are potentially at higher risk for immune cell trafficking to the CNS. CASE DESCRIPTION: We report the first case, to our knowledge, of a 70-year-old man with clear cell renal cell carcinoma with pulmonary metastases treated with lung irradiation, nephrectomy, and chemotherapy prior to switching to single-agent nivolumab IO. The patient presented with new-onset generalized tonic-clonic seizure and left visual field-cut. Review of patient history revealed remote traumatic brain injury (TBI). Brain imaging noted a solid-enhancing right occipital mass that was presumed metastasis versus lymphoma. Cerebrospinal fluid cytology was negative for malignancy but concerning for lymphoproliferative process not determined to be malignant. The patient started steroids and anti-epileptic therapy. After negative systemic cancer re-staging, IO was discontinued and steroids were initiated with demonstrated patient clinical improvement. CONCLUSIONS: We concluded the diagnosis of immune-mediated encephalitis secondary to IO with collection of reactive T-cells within the area of encephalomalacia. The area of encephalomalacia from prior TBI served to compartmentalize the reactive lymphocytes, giving the appearance of a mass. Taken together, new onset seizure in patients on IO might signal encephalitis and CNS metastatic mimicry should be considered in patients with a prior history of TBI and encephalomalacia.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Bross SP, Mongelluzzo GJ, Conger AR, et al. Case Report of Immuno-Oncotherapy (IO) Provoked Encephalitis Mimicking Brain Metastasis in a Patient with History of Traumatic Brain Injury. World Neurosurg. 2020. PMID: 32360731. doi:10.1016/j.wneu.2020.04.177

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。